Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

8/20/2018

Media Contacts:
Kristy Marks
kristy.marks@bausch.com
(908) 927-0683

Don Murphy
don.murphy@zenogroup.com
(212) 299-8970

JOSEPH GORDON NAMED U.S. PRESIDENT OF BAUSCH + LOMB

Veteran Executive Selected to Oversee All Four U.S. Bausch + Lomb Business Units


BRIDGEWATER, N.J., Aug. 20, 2018 – Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TSX:BHC), today announced that Joseph Gordon has been named U.S. president, Bausch + Lomb. In this role, Gordon will oversee the fully integrated U.S. eye care business, inclusive of all four business units - Vision Care, Consumer Health, Surgical and Pharmaceuticals - reporting directly to chairman and CEO of Bausch Health, Joseph C. Papa.

“Bausch + Lomb is an integral part of our business and the largest of the four Bausch Health segments, representing more than 50% of our revenues,” said Papa. “The expansion of Joe’s role reflects the company’s focus on driving growth through our continued transformation – from recently changing our name to Bausch Health and realigning our operating and reportable segments - and the opportunity to build upon Bausch + Lomb’s leadership in eye health as we continue to invest in this important core business. As we look to the next phase of growth for Bausch Health, I am confident that Joe’s strong management background and proven track record of success will further accelerate the growth of Bausch + Lomb, ultimately helping to improve the vision of patients.”

Gordon was most recently the president of Bausch + Lomb’s Consumer Health and Vision Care businesses. During his seven-year tenure at the company, he has led the Bausch + Lomb Consumer Healthcare business to achieve consecutive industry-leading growth for the past six years, bolstered in part by key over-the-counter (OTC) brands such as new LUMIFY™ redness reliever eye drops, the No. 1 doctor recommended redness reliever and Biotrue® multi-purpose solution, the No. 1 multi-purpose solution in households. Both key contact lens brands in Vision Care, Bausch + Lomb ULTRA® and Biotrue® ONEday, are also the fasting growing in their respective segments.

About Bausch + Lomb
Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies Inc., is a leading global eye health organization that is solely focused on helping people see better to live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. For more information, visit www.bausch.com.

###

MTB.0425.USA.18

Print

Number of views (1131)/Comments (0)

x